Making Health Care Work

HOLDING HEALTH INSURERS ACCOUNTABLE—CALPIRG is working to make sure health insurers are providing affordable, high-quality care, and not trying to increase profits at our expense.

LOWER COSTS, BETTER CARE

After years of fighting for the right policies and fighting attacks on health care reform, the state's new health insurance marketplace has opened its doors. Covered California is now offering millions of Californians new choices for health insurance.

From the beginning, CALPIRG has worked to make sure the marketplace would use the buying power of millions of Californians to aggressively push insurers for better deals, more competition and changes in how we pay for health care. The plans announced in California are expected to reduce the cost of health insurance for most individuals, while often offering better benefits.

Thanks to new CALPIRG-supported consumer protections, Californians will not be denied coverage due to pre-existing medical conditions. Prices will not vary by gender. Insurers won't be able to set lifetime maximum dollars amounts for health care, and limits on maximum out-of-pocket costs will protect Californians from medical bankruptcy. All policies sold on the marketplace must cover preventive care, prescription drugs, contraception, medical screenings (e.g., mammograms) and other essential benefits, such as pediatric, mental health, maternity and rehabilitation services.

CALPIRG is continuing to work to provide consumers with access to high-quality, affordable care.

  1. Throughout 2013 and 2014, we plan to educate half a million Californians about our new health insurance options and consumer protections, now in place thanks to the Affordable Care Act. Check out our new health insurance guide for young people.
  2. In fall 2012, we launched our Health Insurance Rate Watch project to investigate rate hikes, and to push back against the industry when those proposed hikes are unjustified. See here for a recent victory for California consumers.
  3. We are fighting the high cost of prescription drugs.
  4. We are calling on the legislature to hold health insurance companies accountable for making sure they are reining in excessive prices and unnecessary paperwork, and to give state officials the power to prohibit insurers from increasing rates if they aren't.

Learn more about our priority campaign to end the pharmaceutical industry's scheme to delay cheaper drugs from entering the market:

Issue updates

Media Hit | Health Care

Pay for Delay

Dr. Michael Wilkes from the University of California, Davis school of Medicine talks about pay-for-delay on his KCRW show "Second Opinion" 

> Keep Reading
Media Hit | Health Care

Consumers are paying more money for certain drugs

The California Public Interest Research Group  released the report on  a practice critics call "Pay for delay."   That's when brand name drug companies pay off generic manufacturers to delay putting generic versions on the market.  As a result, consumers end up paying a lot more. The study found in some cases hundreds of dollars more were spent on meds used to treat cancer,  depression and heart disease. 

> Keep Reading
Media Hit | Health Care

Pharmaceutical companies pay to delay generics

The report, from the California Public Interest Research Group and Community Catalyst, a nonprofit advocate for affordable health care, said pay-for-delay deals enable companies to continue to sell their brand-name drugs at high prices well after their original patents have expired.

> Keep Reading
Media Hit | Health Care

Drug Makers Stall Generics With “Pay For Delay” Says CALPIRG

The California Public Interest Research Group or CALPIRG has released details on what it says is a practice that leads to prescription drug price inflation. CALPIRG calls it “pay for delay.” CALPIRG says the practice of keeping generics off the market makes consumers pay more for medications that treat conditions like cancer and high cholesterol.

> Keep Reading
Media Hit | Health Care

CALPIRG study claims drug companies hold back generic meds

SACRAMENTO, Calif. (KCRA) —A study by a public interest group found Californians have overpaid for medications because brand-made drugs were delayed from reaching pharmacies.

Read more: http://www.kcra.com/news/calpirg-study-claims-drug-companies-hold-back-generic-meds/-/11797728/20945964/-/uh9rdr/-/index.html#ixzz2YrSJnikK

> Keep Reading

Pages

Media Hit | Health Care

Pharmaceutical companies pay to delay generics

The report, from the California Public Interest Research Group and Community Catalyst, a nonprofit advocate for affordable health care, said pay-for-delay deals enable companies to continue to sell their brand-name drugs at high prices well after their original patents have expired.

> Keep Reading
Media Hit | Health Care

Drug Makers Stall Generics With “Pay For Delay” Says CALPIRG

The California Public Interest Research Group or CALPIRG has released details on what it says is a practice that leads to prescription drug price inflation. CALPIRG calls it “pay for delay.” CALPIRG says the practice of keeping generics off the market makes consumers pay more for medications that treat conditions like cancer and high cholesterol.

> Keep Reading
Media Hit | Health Care

CALPIRG study claims drug companies hold back generic meds

SACRAMENTO, Calif. (KCRA) —A study by a public interest group found Californians have overpaid for medications because brand-made drugs were delayed from reaching pharmacies.

Read more: http://www.kcra.com/news/calpirg-study-claims-drug-companies-hold-back-generic-meds/-/11797728/20945964/-/uh9rdr/-/index.html#ixzz2YrSJnikK

> Keep Reading
News Release | CALPIRG | Health Care

Twenty Top Generic Drugs Delayed By Industry Payoffs

The report, “Top Twenty Pay-for-Delay Drugs: How Drug Industry Payoffs Delay Generics, Inflate Prices and Hurt Consumers” reveals that these drugs were subject to an industry practice called “pay for delay,” in which brand name pharmaceutical companies pay off generic drug manufacturers to keep lower cost equivalents off the market, forcing consumers to pay higher brand-name drug prices.

> Keep Reading
Media Hit | Health Care

High court rules 'pay-for-delay' drug deals can face antitrust suits

"While we're disappointed the court did not take the next step and outlaw this anti-competitive practice, we expect Congressto now give this issue the attention it deserves and end these deals once and for all," said Austin Price, field director for the California Public Interest Research Group.

> Keep Reading

Pages

Report | CALPIRG Education Fund | Consumer Protection, Health Care

Your Price May Vary

New report finds that the price charged for common surgeries varies dramatically from one region to another within California.

> Keep Reading
Report | CALPIRG Education Fund | Health Care

At Stake: What’s on the Line for Health Care Consumers in the Pending Supreme Court Case

The outcome of the U.S. Supreme Court’s ruling on the Affordable Care Act (ACA) will have far reaching impacts on consumers. The law is already working to improve the quality of care and reduce costs, with millions of Americans experiencing concrete improvements in their coverage.

> Keep Reading
Report | CALPIRG Education Fund | Health Care

Making the Grade

Health care exchanges, authorized by 2010’s health reform law, offer the states the chance to address the twin problems of cost and quality, and help consumers get a fair shake when buying insurance. 

> Keep Reading
Report | CALPIRG Education Fund | Health Care

Building a Better Health Care Marketplace

The creation of a new health insurance exchange offers our state the chance to build a better marketplace for health care.  The exchange can help individuals and small businesses by increasing competition and improving choices in the state’s insurance market.  By providing better options and better information, and negotiating on behalf of its enrollees, the exchange can level the playing field for consumers.

> Keep Reading
Report | CALPIRG Education Fund | Health Care

Building a Better Health Care Marketplace Brief #7

The exchange is a store where consumers can buy health insurance products – and anyone who’s worked retail knows that however much work has gone into crafting strong policies and building an efficient back-office, if customers  can’t understand, compare and choose the products that are right for them, it just won’t work.  

> Keep Reading

Pages

View AllRSS Feed

Support us

We’ve got a chance to clean up the health care industry in California, but with lobbyists lining the halls of the state capitol, we need your support.

PRIORITY ACTION

When Big Pharma pays off their competition to keep them from selling lower priced generic drugs, we all pay. Each year this costs Americans an added $3.5 billion.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.